Chemokine stimulation of human neutrophil [Ca2+]i signaling in biologic environments

Carl J. Hauser, Zoltan Fekete, David H. Livingston, Edwin A. Deitch

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Clinical neutrophil (PMN) priming is the net result of multiple stimuli, with intracellular calcium ([Ca2+]i) being a key second messenger for PMN agonists such as the chemokines. Thus, [Ca2+]i measurement may be a robust tool for the assessment of global PMN activation. [Ca2+]i is difficult to measure in complex biologic environments, however, so data in this area are limited. We therefore developed an in vitro system to measure the effects of chemokines on PMN [Ca2+]i. PMN were isolated from volunteer blood. PMN [Ca2+]i responses to interleukin (IL)-8 and Growth-Related Oncogene (GRO)-α were studied by fura-2-acetoxymethyl ester fluorescence with or without reincubation in autologous plasma just prior to study. The effects of IL-8 and GRO-α on PMN [Ca2+]i at ascending doses, with or without plasma reincubation, given sequentially and in the presence or absence of extracellular calcium, were studied. PMN basal [Ca2+]i was increased by plasma, as were low-dose priming and higher-dose spike responses to IL-8. GRO-α caused a more pronounced priming of PMN [Ca2+]i than IL-8 at low doses, although significantly lower peak responses were observed with GRO-α than IL-8 at higher doses. Plasma suppressed both priming and spike responses to GRO-α. When given serially at clinically relevant agonist doses, GRO-α was permissive of IL-8 signaling, whereas IL-8 blocked GRO-α signaling. IL-8 generates high [Ca2+]i spikes using intracellular calcium stores only. GRO-α produces lower [Ca2+]i spikes despite using both intra- and extracellular stores. Plasma preincubation has profound effects on PMN [Ca2+]i responses to chemokines. These can be measured accurately, as described. In clinically relevant environments, IL-8 and GRO-α interact in a regulatory fashion. GRO-α may act as a priming agent, with IL-8 activating PMN functions requiring high [Ca2+]i. This cross-cooperation is probably terminated by IL-8 regulation of GRO-α activity at the C-X-C chemokine receptor 2.

Original languageEnglish (US)
Pages (from-to)324-328
Number of pages5
JournalShock
Volume10
Issue number5
DOIs
StatePublished - Nov 1998

Fingerprint

Interleukin-8
Oncogenes
Chemokines
Neutrophils
Growth
Calcium
CXC Chemokines
Chemokine Receptors
Second Messenger Systems
Volunteers
Esters
Fluorescence

All Science Journal Classification (ASJC) codes

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Hauser, Carl J. ; Fekete, Zoltan ; Livingston, David H. ; Deitch, Edwin A. / Chemokine stimulation of human neutrophil [Ca2+]i signaling in biologic environments. In: Shock. 1998 ; Vol. 10, No. 5. pp. 324-328.
@article{ed93c1ab74f142119f07c1b43b07f919,
title = "Chemokine stimulation of human neutrophil [Ca2+]i signaling in biologic environments",
abstract = "Clinical neutrophil (PMN) priming is the net result of multiple stimuli, with intracellular calcium ([Ca2+]i) being a key second messenger for PMN agonists such as the chemokines. Thus, [Ca2+]i measurement may be a robust tool for the assessment of global PMN activation. [Ca2+]i is difficult to measure in complex biologic environments, however, so data in this area are limited. We therefore developed an in vitro system to measure the effects of chemokines on PMN [Ca2+]i. PMN were isolated from volunteer blood. PMN [Ca2+]i responses to interleukin (IL)-8 and Growth-Related Oncogene (GRO)-α were studied by fura-2-acetoxymethyl ester fluorescence with or without reincubation in autologous plasma just prior to study. The effects of IL-8 and GRO-α on PMN [Ca2+]i at ascending doses, with or without plasma reincubation, given sequentially and in the presence or absence of extracellular calcium, were studied. PMN basal [Ca2+]i was increased by plasma, as were low-dose priming and higher-dose spike responses to IL-8. GRO-α caused a more pronounced priming of PMN [Ca2+]i than IL-8 at low doses, although significantly lower peak responses were observed with GRO-α than IL-8 at higher doses. Plasma suppressed both priming and spike responses to GRO-α. When given serially at clinically relevant agonist doses, GRO-α was permissive of IL-8 signaling, whereas IL-8 blocked GRO-α signaling. IL-8 generates high [Ca2+]i spikes using intracellular calcium stores only. GRO-α produces lower [Ca2+]i spikes despite using both intra- and extracellular stores. Plasma preincubation has profound effects on PMN [Ca2+]i responses to chemokines. These can be measured accurately, as described. In clinically relevant environments, IL-8 and GRO-α interact in a regulatory fashion. GRO-α may act as a priming agent, with IL-8 activating PMN functions requiring high [Ca2+]i. This cross-cooperation is probably terminated by IL-8 regulation of GRO-α activity at the C-X-C chemokine receptor 2.",
author = "Hauser, {Carl J.} and Zoltan Fekete and Livingston, {David H.} and Deitch, {Edwin A.}",
year = "1998",
month = "11",
doi = "10.1097/00024382-199811000-00003",
language = "English (US)",
volume = "10",
pages = "324--328",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Chemokine stimulation of human neutrophil [Ca2+]i signaling in biologic environments. / Hauser, Carl J.; Fekete, Zoltan; Livingston, David H.; Deitch, Edwin A.

In: Shock, Vol. 10, No. 5, 11.1998, p. 324-328.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chemokine stimulation of human neutrophil [Ca2+]i signaling in biologic environments

AU - Hauser, Carl J.

AU - Fekete, Zoltan

AU - Livingston, David H.

AU - Deitch, Edwin A.

PY - 1998/11

Y1 - 1998/11

N2 - Clinical neutrophil (PMN) priming is the net result of multiple stimuli, with intracellular calcium ([Ca2+]i) being a key second messenger for PMN agonists such as the chemokines. Thus, [Ca2+]i measurement may be a robust tool for the assessment of global PMN activation. [Ca2+]i is difficult to measure in complex biologic environments, however, so data in this area are limited. We therefore developed an in vitro system to measure the effects of chemokines on PMN [Ca2+]i. PMN were isolated from volunteer blood. PMN [Ca2+]i responses to interleukin (IL)-8 and Growth-Related Oncogene (GRO)-α were studied by fura-2-acetoxymethyl ester fluorescence with or without reincubation in autologous plasma just prior to study. The effects of IL-8 and GRO-α on PMN [Ca2+]i at ascending doses, with or without plasma reincubation, given sequentially and in the presence or absence of extracellular calcium, were studied. PMN basal [Ca2+]i was increased by plasma, as were low-dose priming and higher-dose spike responses to IL-8. GRO-α caused a more pronounced priming of PMN [Ca2+]i than IL-8 at low doses, although significantly lower peak responses were observed with GRO-α than IL-8 at higher doses. Plasma suppressed both priming and spike responses to GRO-α. When given serially at clinically relevant agonist doses, GRO-α was permissive of IL-8 signaling, whereas IL-8 blocked GRO-α signaling. IL-8 generates high [Ca2+]i spikes using intracellular calcium stores only. GRO-α produces lower [Ca2+]i spikes despite using both intra- and extracellular stores. Plasma preincubation has profound effects on PMN [Ca2+]i responses to chemokines. These can be measured accurately, as described. In clinically relevant environments, IL-8 and GRO-α interact in a regulatory fashion. GRO-α may act as a priming agent, with IL-8 activating PMN functions requiring high [Ca2+]i. This cross-cooperation is probably terminated by IL-8 regulation of GRO-α activity at the C-X-C chemokine receptor 2.

AB - Clinical neutrophil (PMN) priming is the net result of multiple stimuli, with intracellular calcium ([Ca2+]i) being a key second messenger for PMN agonists such as the chemokines. Thus, [Ca2+]i measurement may be a robust tool for the assessment of global PMN activation. [Ca2+]i is difficult to measure in complex biologic environments, however, so data in this area are limited. We therefore developed an in vitro system to measure the effects of chemokines on PMN [Ca2+]i. PMN were isolated from volunteer blood. PMN [Ca2+]i responses to interleukin (IL)-8 and Growth-Related Oncogene (GRO)-α were studied by fura-2-acetoxymethyl ester fluorescence with or without reincubation in autologous plasma just prior to study. The effects of IL-8 and GRO-α on PMN [Ca2+]i at ascending doses, with or without plasma reincubation, given sequentially and in the presence or absence of extracellular calcium, were studied. PMN basal [Ca2+]i was increased by plasma, as were low-dose priming and higher-dose spike responses to IL-8. GRO-α caused a more pronounced priming of PMN [Ca2+]i than IL-8 at low doses, although significantly lower peak responses were observed with GRO-α than IL-8 at higher doses. Plasma suppressed both priming and spike responses to GRO-α. When given serially at clinically relevant agonist doses, GRO-α was permissive of IL-8 signaling, whereas IL-8 blocked GRO-α signaling. IL-8 generates high [Ca2+]i spikes using intracellular calcium stores only. GRO-α produces lower [Ca2+]i spikes despite using both intra- and extracellular stores. Plasma preincubation has profound effects on PMN [Ca2+]i responses to chemokines. These can be measured accurately, as described. In clinically relevant environments, IL-8 and GRO-α interact in a regulatory fashion. GRO-α may act as a priming agent, with IL-8 activating PMN functions requiring high [Ca2+]i. This cross-cooperation is probably terminated by IL-8 regulation of GRO-α activity at the C-X-C chemokine receptor 2.

UR - http://www.scopus.com/inward/record.url?scp=0032198868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032198868&partnerID=8YFLogxK

U2 - 10.1097/00024382-199811000-00003

DO - 10.1097/00024382-199811000-00003

M3 - Article

C2 - 9840646

AN - SCOPUS:0032198868

VL - 10

SP - 324

EP - 328

JO - Shock

JF - Shock

SN - 1073-2322

IS - 5

ER -